BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the...
Leadership
Cuong Viet Do M.B.A.
President, CEO & Director
Joanne Wendy Kim CPA
CFO, Treasurer & Corporate Secretary
Joseph M. Palumbo M.D.
Executive VP of R&D and Chief Medical Officer
Clarence N. Ahlem
Senior Vice President of Operations
Penelope Markham Ph.D.
Senior Vice President of Liver Disease Program
Denise Smith
Senior Vice President of Manufacturing & Development
Christopher L. Reading Ph.D.
Senior Vice President of Alzheimer's Disease Program